CRON Cronos Group Inc: רווח נקי למניה ב-12 החודשים האחרונים

Oversupply risks and the tax burden are hindering the profitability of Cronos Group Inc. The annual EPS TTM trend shown on GURU.Markets visualizes this process, where the parameter has settled at 62.60. Margins are stagnating due to marketing expenses, yet scaling potential remains hidden in R&D and the biosynthesis of rare components via fermentation.

Cronos Group Inc. (CRON) technological advantage in cannabinoid synthesis directly impacts margins, as quantified by the net earnings per share dynamics over the last twelve months. By analyzing the historical EPS YoY TTM delta, an investor determines the actual pace of business scaling, where abnormal growth peaks often signal market overheating and the risk of a subsequent price correction.